Asset 2 Conferences
Linterman Michelle - Profile picture

Michelle Linterman

Babraham Institute, UK

Michelle Linterman is Group Leader at the Babraham Institute. Her laboratory’s principle research focus is on how different cell types collaborate in the germinal centre to generate a robust antibody response following vaccination. Vaccination is one of the most successful, cost-effective interventions for combating infectious disease. Despite this enormous success, there are still multiple circumstances that require a vaccination solution, including vaccines that protect against HIV and malaria, and a way to improve vaccine efficacy in the later years of life. An understanding of the cellular and molecular basis of a productive germinal centre response may be the key to rational vaccine design in cases where breakthroughs in vaccine development are needed.

Speaker at